Trinity Capital Inc. Provides $15 Million in Growth Capital to Cagent Vascular Inc.
PHOENIX, Feb. 20, 2025 /PRNewswire/ — Trinity Capital Inc. (NASDAQ: TRIN) (“Trinity Capital”), a leading alternative asset manager, today announced the commitment of $15 million in growth capital to Cagent Vascular Inc., a leading developer of serration technology for vessel dilation in endovascular interventions. This…